Detection of intrahepatic human islets following combined liver-islet allotransplantation by Ricordi, C et al.
1 
I 
Pancreas 
Vol. 7. No.4. pp. 507-509 
'; 1992 Raven Press. Ltd .. New York 
Case Report 
Detection of Intrahepatic Human Islets Following 
Combined Liver-Islet Allotransplantation 
Camillo Ricordi. Andreas Tzakis. *Rodolfo Alejandro. Yijun Zeng, 
Anthony J. Demetris. Patricia Carroll. John J. Fung, *Daniel H. Mintz. and 
Thomas E. Starzl 
Departments ot'Surgery and Pathology, University 0/ Pittsburgh School of Medicine, Pittsburgh, Pennsvlvania. and 
* Diabetes Research institute. University 0/ Miami School of Medicine. Miami. Florida. U.S.A. 
SummarY: This article describes the localization of intact Insulin-containing 
intrahepilllc islets after combined liver-islet allotransplantation. The patient 
was a 36-year-old woman who underwent upper abdominal exenteration for 
neuroendocrine carcinoma: 289.000 islets were transplanted via portal vein 
infusion Immediately after complete revascularization of the liver. Immuno-
suppressIOn was wnh low-dose FK-506. OKT3 and steroids were used to treat 
one rejection episode 2 weeks after transplantation. but the patient subse-
quently developed multiple infections and died 109 days after transplantation. 
At autopsy. the transplanted liver did not show any sign of rejection and 
well-pt!t!served islets were present in portal triads sampled from the anterior 
inferior edge of the right lobe. Immunohistochemical labeling confirmed the 
presence of insulin-containing cells. This finding indicated that human islets 
can survive after intrahepatic allotransplantation. despite positive cross-match 
with no HLA antigen match. suggesting that upper abdominal exenteration and 
liver transplantation may constitute a protective factor for the surVIval of al-
logeneIc human islets. Key Words: Human-Islet-Transplantation. 
--------------- ----. ----- .-----
Recent improvements in islet separation and pu-
rification procedures (1-6) have resulted in pro-
longed insulin independence after human islet allo-
transplantation (7-10). demoRstrnnng that it is pos-
\Ible to reverse diabetes with islets obtained from 
~me (7) or multiple (X.9) pancreas donors. The ma,jor 
obstacle to wider clinical application of islet trans-
plantation is the vulnerability of the human islets to 
immune rejection. 
I t has been shown In both animals and humans 
t hat liver allografts can induce a ~tate of donor-
~pecilic unresponsiveness to vascularized organ al-
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lografts such as the heart or kidney (10). Similar 
results can be achieved with infusion of allogeneic 
intrahepatic islets when islets are infused 24 h after 
a liver transplant ( ((l). 
This article Jescribes localization of insulin-
containing intrahepatic islets at autopsy in a 36-
year-old woman who underwent upper abdominal 
exenteration and combined liver-Islct allotransplan-
tation (7l. 
CASE REPORT 
The patient was a 3h-vear-oIJ woman with a his-
tory of neurofibromatOSIs since chilJhood. In 1980. 
she developed hiliary ohstruction and secondarv 
biliary cirrhosis with portal hypertcnsion and 
esophageal varices (treated with endoscopic sclero-
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therapy). In 1989. she was found to have a periam-
pullary pancreatic mass diagnosed by biopsy to be a 
neuroendocrine carcinoma. After exploratory lap-
arotomy, a portal angiogram was done. demonstrat-
ing splenic vein invasion by the tumor. which ex-
cluded a splenorenal shunt as a therapeutic option. 
A decision was made to perform a liver transplant 
and not to decompress the portal system with an 
alternative procedure. to avoid subsequent hepatic 
encephalopathy. 
On February 10. 1990. the patient underwent 
combined liver and islet allotransplantation follow-
ing resection of a cluster of abdominal organs in-
cluding the liver. stomach. duodenum. proximal je-
junum. transverse colon. spleen. and the entire pan-
creas. The patient was not diabetic before surgery 
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and thus had not been on insulin. There was no 
C-peptide response to glucagon in the interval be-
tween native organ removal and islet infusion, indi-
cating that all native insulin-producing cells were 
removed. 
Pancreas and liver were obtained from a multi-
organ. 19-year-old. female. cytomegalovirus 
(CMV)-seropositive donor. The recipient was 
CMV -seronegative, The islets were separated by a 
modification (2) of the automated method for hu-
man islet isolation ( I). Purification of the endocrine 
component was by Eurocollins-Ficoll discontinu-
ous gradients (II). using a cell separator (3.4) 
(COBE 2991. Lakewood. CO. U.S.A.). Immedi-
ately following complete liver allograft revascular-
ization (7), 289.000 islets. average diameter of 150 fJ. 
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FIG. I. A: Photomlcrogrolph of human 1~fc:ts (lopl In a ponal triad IO<J dav~ Illllowln!! human Islel allolr:tn~plantatlonK The IS/c:h w.:rc: 
cllnt:ttnc:d within small venules In the interstitium 01 the ponal tract. rhe IIvc:r showc:d ~tcato"y anJ cholestasls but no Inl1ammatorv ~ell 
lrlliltratc:. rhe parc:nchvmal chanlZes wc:re a{(nbuted to the sepsIs anJ total parentc:ral nutrition thematoxvlln·eo'in .. X51. B: Immunu· 
histochemical statn tlmmunopc:roxldasellor insulin revealed beta cells (darklv ,tamln!! cells .. X,'I. 
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(12.13). were transplanted via portal vein infusion. 
The cytotoxic cross-match was strongly positive 
(100%1. and there was a complete six-antigen HLA 
mismatch. Immunosuppression was with FK-506 (4 
mg twice a day. i. v.). Two weeks after transplanta-
tion. a liver biopsy was performed because of he-
patic dysfunction: the biopsy demonstrated acute 
cellular rejection. The patient was treated with 7 
Jays of OKT3 and steroids. but she subsequently 
developed CMV hepatitis. which was treated with 
ganciclovir (DHPGl. Her clinical status deterio-
rated because of multiple respiratory complica-
tions. renal infections (Klebsiella. Aeromollas). and 
the CMV hepatitis. 
On May 16. 1990. the patient developed gram-
negative sepsis (Aeromolllls hvJropizililil. and all 
immunosuppressive therapy was discontinued on 
May It). Despite aggressive antibiotic and support-
ive medical therapy. the patient became progres-
"ively obtunded and died lOt) days after transplan-
tation. Postmortem examination revealed enteritis 
;tnd hronchopneumonia. with subsequent sepsis as 
the cause of death. The liver allograft showed ste-
atosis and cholestasis. but no intlammatory cell in-
filtrate or CMV inclusions. The parenchymal 
changes noted above were attributed to the sepsis 
and total parenteral nutririon. Pancreatic islets were 
Jetected in several portal triaus in tissue sections 
from the anterior inferior edge of the right lohe of 
the liver. The islets were contained within small 
venulcs in the interstitium of the portal tracts (Fig. 
I A l. An immunohistochemical ~tain for insulin con-
firmed the presence of insulin-containing cells (Fig. 
I B l. 
It is or note that the pauent never hecame insulin 
independent after islet allotransplantation. We at-
trlhuted the exogenous insulin requirement to the 
complicated postoperative course (sepsis' and the 
need for I.:ontlnuous total paren.teillnutntion. Nev-
crtheless. signiticant plasma C-peptide levels (1-1) 
were ohserved during the postoperative course: 
2.15 :':: 1.27 [".\1. 1/ =~lK versus C-pepude plasma 
levels in normal controls of 2.1t) ::!: 1.22 p.\1. 1/ = 10. 
DISCUSS(ON 
rhe findings in this patient Indicated that human 
i"lets C;ln survIve in the liver of transplanted pa-
tlcnts. Jcsplte positive cross-match. no HLA anti-
.'!en matl.:h. ,lnd immunosuppressive monotherapy 
\\ Ith low-dose FK-SOo. \\ hich was discontinued 12 
davs hctore the pallen! Liied .. \1-.0. [he findings "ll~-
gest that upper abdominal exenteration and liver 
transplantation may constitute a favorable environ-
ment for allogeneic human islets. providing addi-
tional evidence in support of previous experimental 
results on combined liver-islet transplantation (IO)' 
Since this patient. we have been able to document 
the presence of insulin-containing cells in both 
wedge and needle liver biopsies in patients who re-
ceived either liver-islet or kidney-islet allografts 
( 15). 
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